B. Potts

Gas-chromatographic quantification of methylphenidate in plasma with use of solid-phase extraction and nitrogen-sensitive detection.

M. Vore, B. Potts, C. A. Martin, 1984, Clinical chemistry.

Analysis of the Enantiomers of Fluoxetine and Norfluoxetine in Plasma and Tissue Using Chiral Derivatization and Normal-Phase Liquid Chromatography

C. Parli, B. Potts, 1992 .

Relation of Plasma and Brain Concentrations of the Anticonvulsant Ameltolide to Its Pharmacologic Effects

D. Lodge, J. Leander, C. Parli, 1992, Epilepsia.

Discovery and anticonvulsant activity of the potent metabolic inhibitor 4-amino-N-(2,6-dimethylphenyl)-3,5-dimethylbenzamide.

E. Beedle, D. Robertson, C. R. Clark, 1987, Journal of medicinal chemistry.

Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection.

B. Potts, J. Bao, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.

C. Whitesitt, W. S. Marshall, B. R. Macdonald, 1992, The Journal of pharmacology and experimental therapeutics.

Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.

C. Parli, B. Potts, S. Gabriel, 1989, Drug metabolism and disposition: the biological fate of chemicals.

Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex

D. Wong, K. Perry, F. Bymaster, 2000, Neuropsychopharmacology.

Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size.

P. J. Simpson, B. R. Macdonald, R. A. Hahn, 1990, The Journal of pharmacology and experimental therapeutics.